Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibr…
Drug Manufacturers - Specialty & Generic
DE, Hamburg [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 43.16 | 44.06 | 43.66 | 35.55 | 36.33 | 32.83 | 29.75 | 35.59 | 32.05 | 29.84 | 29.77 | 25.10 | 24.52 | 23.16 | 22.40 | |
| Profit Margin | -106.59 | 5.90 | 8.42 | 2.84 | -29.59 | -7.80 | 12.94 | 16.73 | 9.42 | 22.42 | 8.55 | 1.25 | 34.87 | -23.38 | -10.74 | |
| Operating Margin | -99.10 | 3.10 | 6.50 | -3.67 | -24.84 | -7.13 | 9.12 | 19.05 | 14.55 | 20.63 | 14.02 | 9.69 | 4.42 | 1.66 | -13.70 | |
|
EPS Growth
|
47.56 | 106.98 | 100.00 | -66.67 | -1,150.00 | 74.71 | 344.82 | 53.85 | -20.00 | 256.25 | -56.14 | -84.00 | 3,150.00 | -176.15 | 52.53 | |
| EPS EUR | -43.00 | 3.00 | 6.00 | 2.00 | -21.00 | -5.31 | 13.00 | 20.00 | 16.00 | 57.00 | 25.00 | 4.00 | 130.00 | -99.00 | -47.00 | |
| Return on Assets (ROA) | -31.04 | 1.70 | 3.09 | 1.10 | -11.19 | -3.11 | 5.72 | 7.84 | 3.64 | 10.90 | 3.23 | 0.43 | 9.64 | -7.78 | -3.65 | |
| Return on Equity (ROE) | -41.03 | 2.47 | 4.58 | 1.62 | -16.00 | -4.41 | 8.90 | 12.92 | 7.33 | 19.85 | 8.00 | 0.87 | 15.64 | -14.80 | -7.49 | |
| Return on Invested Capital (ROIC) | -34.61 | 0.91 | 4.02 | 0.93 | -13.03 | -4.80 | 7.38 | 10.56 | 6.56 | 16.79 | 4.38 | 0.97 | 1.31 | 0.84 | -3.73 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 9.01 | 6.69 | 7.66 | 7.72 | 7.58 | 9.59 | 7.95 | 8.20 | 28.46 | 14.83 | 39.22 | 33.63 | 22.95 | 22.45 | 27.24 | |
| Debt/Equity | 11.91 | 9.71 | 11.35 | 11.41 | 10.85 | 13.61 | 12.37 | 13.53 | 57.42 | 27.00 | 97.08 | 68.06 | 37.23 | 42.68 | 55.92 | |
| Debt/EBITDA | 115.41 | -89.21 | -7.45 | -217.83 | -208.66 | -242.81 | -211.21 | -112.17 | 210.64 | 5.71 | 152.95 | 70.52 | -196.37 | 97.20 | -1,609.51 | |
|
Debt/Capitalization
|
10.64 | 8.85 | 10.19 | 10.24 | 9.78 | 11.98 | 11.01 | 11.92 | 36.48 | 21.26 | 49.26 | 40.50 | 27.13 | 29.91 | 35.86 | |
| Long-Term Debt/Capitalization | 3.39 | 2.60 | 1.58 | 2.67 | 0.01 | 4.91 | 4.49 | 3.28 | 6.09 | 11.95 | 48.12 | 38.99 | 25.13 | 29.23 | 29.88 | |
| Interest Debt per Share EUR | 0.13 | 0.13 | 0.16 | 0.16 | 0.16 | 0.18 | 0.19 | 0.23 | 1.32 | 0.79 | 3.14 | 3.25 | 3.14 | 2.94 | 3.61 | |
| Debt Growth | 16.57 | -2.85 | 30.28 | 4.12 | -0.93 | 24.99 | 6.47 | 25.65 | 558.86 | -39.73 | 304.58 | 6.23 | 4.26 | -1.22 | 23.59 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 260.76 | 264.29 | 194.55 | 260.03 | 314.55 | 378.92 | 295.99 | 230.60 | 73.34 | 127.25 | 262.37 | 316.05 | 339.26 | 317.93 | 194.41 | |
| Quick Ratio | 251.59 | 255.69 | 186.25 | 252.82 | 308.49 | 369.51 | 290.44 | 224.73 | 69.67 | 124.37 | 256.37 | 309.54 | 331.31 | 309.10 | 187.76 | |
| Cash Ratio | 124.51 | 64.30 | 41.50 | 115.30 | 117.18 | 147.30 | 78.90 | 114.38 | 27.27 | 55.56 | 154.81 | 202.52 | 215.50 | 122.93 | 109.97 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 1,000.50 | 1,096.70 | 1,269.49 | 2,300.29 | 2,320.40 | 1,932.43 | 2,862.75 | 2,461.16 | 1,941.47 | 4,653.52 | 2,916.98 | 2,761.73 | 1,808.60 | 1,935.90 | 1,963.01 | |
| Receivables Turnover | 878.79 | 444.30 | 502.94 | 561.80 | 471.93 | 342.29 | 575.38 | 551.52 | 485.95 | 502.07 | 359.65 | 365.96 | 349.66 | 292.69 | 382.95 | |
| Payables Turnover | 463.46 | 442.92 | 445.46 | 883.89 | 822.41 | 636.17 | 736.92 | 883.16 | 671.30 | 845.90 | 1,001.14 | 881.76 | 642.57 | 593.55 | 451.44 | |
|
Asset Turnover
|
29.12 | 28.80 | 36.72 | 38.71 | 37.79 | 39.85 | 44.25 | 46.82 | 38.61 | 48.63 | 37.80 | 34.24 | 27.65 | 33.29 | 33.99 | |
| Fixed Turnover | 222.75 | 298.92 | 321.21 | 321.05 | 354.54 | 372.20 | 333.06 | 378.87 | 345.06 | 414.73 | 186.61 | 148.51 | 127.54 | 115.57 | 96.88 | |
| Coverage | ||||||||||||||||
| Interest Coverage | -9,768.82 | 198.04 | 280.25 | -172.24 | -1,141.76 | -393.65 | 674.39 | 2,057.91 | 2,973.43 | 2,989.70 | 839.51 | 573.22 | 295.22 | 95.02 | -912.24 | |
| Asset Coverage | 700 | 800 | 700 | 800 | 900 | 800 | 900 | 900 | 200 | 400 | 100 | 200 | 300 | 300 | 300 | |
| Cash Flow Coverage (CFGR) | -165.49 | 7.01 | 60.71 | 68.71 | 38.61 | -17.62 | 68.22 | 233.67 | 5.70 | 136.50 | 9.12 | 9.09 | 23.83 | 40.09 | 5.42 | |
| EBITDA Coverage | -3,900 | 1,000 | 700 | 500 | 700 | 600 | 500 | 3,200 | 4,600 | 3,600 | 1,600 | 1,100 | 1,000 | 700 | - - | |
| Dividend Coverage | 1,100 | -800 | - - | - - | 9,100 | 300 | -2,900 | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | 100 | 100 | 100 | 100 | - - | 200 | 100 | 200 | 200 | 100 | 100 | 100 | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | 1.78 | 0.12 | - - | - - | 0.06 | 0.38 | 0.10 | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -19.99 | 1.02 | 2.49 | 0.79 | -5.72 | -1.44 | 3.01 | 2.79 | 1.23 | 3.13 | 1.11 | 0.14 | 3.05 | -6.52 | -2.23 | |
|
Price/Earnings (P/E)
|
-500.21 | 9,764.35 | 4,022.70 | 12,733.08 | -1,749.15 | -6,923.93 | 3,324.66 | 3,581.00 | 8,124.18 | 3,195.92 | 9,044.91 | 74,157.66 | 3,281.64 | -1,534.86 | -4,486.54 | |
| Price/Earnings Growth (PEG) | 10.52 | -91.28 | 40.23 | -191.00 | 1.52 | 92.67 | -9.64 | 66.50 | -406.21 | 12.47 | -161.11 | -882.83 | 1.04 | 8.71 | 85.42 | |
|
Price/Book (P/B)
|
205.26 | 240.86 | 184.38 | 206.84 | 279.84 | 305.05 | 296.01 | 462.76 | 595.81 | 634.45 | 723.47 | 644.07 | 513.34 | 227.10 | 336.17 | |
| Price/Tangible Book (P/TB) | 205.26 | 240.86 | 184.38 | 206.84 | 279.84 | 305.05 | 296.01 | 462.76 | 595.81 | 634.45 | 723.47 | 644.07 | 513.34 | 227.10 | 336.17 | |
| Price/Sales (P/S) | 533.19 | 576.02 | 338.82 | 361.57 | 517.65 | 539.86 | 430.07 | 599.28 | 764.93 | 716.58 | 773.05 | 929.41 | 1,144.31 | 358.78 | 481.78 | |
|
Price/Cash Flow (P/CF)
|
-1,041.42 | 35,407.97 | 2,675.85 | 2,638.84 | 6,682.59 | -12,724.57 | 3,508.41 | 1,463.55 | 18,199.87 | 1,721.76 | 8,175.04 | 10,410.36 | 5,785.69 | 1,327.41 | 11,088.88 | |
| Price/Free CF (P/FCF) | -945.66 | -20,750.83 | 13,527.25 | 17,706.28 | 30,324.48 | -5,321.64 | 13,215.42 | 1,723.18 | -29,156.42 | 2,095.51 | 33,470.81 | -8,565.84 | 214,701.03 | 12,394.49 | -2,068.03 | |
| Price/Operating CF (P/OCF) | -1,041.42 | 35,407.97 | 2,675.85 | 2,638.84 | 6,682.59 | -12,724.57 | 3,508.41 | 1,463.55 | 18,199.87 | 1,721.76 | 8,175.04 | 10,410.36 | 5,785.69 | 1,327.41 | 11,088.88 |